Fox Chase Cancer Center News

PHILADELPHIA (March 11, 2025) — Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists (CAP) based on the results of an on-site inspection.

PHILADELPHIA (March 4, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Caryn Karff, MS, RT, CRA, as the new Administrative Director of Radiology for Fox Chase Cancer Center, Temple University Hospital – Jeanes Campus, and Temple Health – Chestnut Hill Hospital.

PHILADELPHIA (February 27, 2025)—Fox Chase Cancer Center’s Alycia So, MD, an Assistant Professor in the Department of Surgery, was recently inducted as a fellow into the Philadelphia Academy of Surgery.

PHILADELPHIA (February 27, 2025) — Fox Chase Cancer Center’s Department of Bone Marrow Transplant and Cellular Therapy (BMT) has received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT).

PHILADELPHIA (February 25, 2025) — Researchers at Fox Chase Cancer Center recently published two reviews on the complex role of AKT, also known as protein kinase B, in the development and treatment of cancer.

PHILADELPHIA (February 25, 2025) — Erin K. Tagai, PhD, MPH, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center, has received a grant from the Prevent Cancer Foundation to fund development of a ChatBot for patients receiving genetic testing results.

PHILADELPHIA (February 24, 2025) — Starting treatment within 60 days of initial evaluation significantly improves survival rates for rectal cancer patients, according to a study released today by researchers at Fox Chase Cancer Center and Temple Health.

PHILADELPHIA (February 21, 2025) — Fox Chase Cancer Center’s Hossein Borghaei, DO, MS, Elizabeth Plimack, MD, MS, and Lorenzo Galluzzi, PhD, have been named to the 2024 list of Highly Cited Researchers by Clarivate, a leading global provider of transformative intelligence.